The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome

Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes, hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic cardiovascular diseases. These conditions frequently require multiple medications, raising the risk of polypharmacy, a...

Descripción completa

Detalles Bibliográficos

Autores principales:	Rizwana Sultana, Fatoumatta Sissoho, Vinod P. Kaushik, Mukaila A. Raji
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2022-08-01
Colección:	Life
Materias:	diabetes obesity obstructive sleep apnea GLP I-RA
Acceso en línea:	https://www.mdpi.com/2075-1729/12/8/1222
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!